ArticleJournal of clinical lipidology2007

Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS).

Francesca Vittone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.